MBRX ▼ -0.2% - Moleculin Biotech, Inc.
$MBRX - Moleculin Completes Dosing Patients in Part A of Pivotal MIRACLE Trial; Comprehensive Data Readout on Track for Q1 2027
30-OCT-2026 08:40 AM ET
Share this post
More filings for $MBRX
MBRX - Moleculin Biotech, Inc. - SEC Filing Update (16-NOV-2026) | ThinkSabio - Stocks SimplifiedNov 16, 2026MBRX ▲ +3.3% - Moleculin Biotech, Inc.Nov 12, 2026MBRX ▲ +0.9% - Moleculin Biotech, Inc.Nov 10, 2026MBRX ▲ +2.3% - Moleculin Biotech, Inc.Nov 4, 2026MBRX ▼ -95.0% - Moleculin Biotech, Inc.Oct 20, 2026MBRX ▼ -10.8% - Moleculin Biotech, Inc.Oct 16, 2026
View full $MBRX filing history →💬 Comments
Loading comments…
Leave a comment
